Jeff Yass’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,900
| Closed | -$172K | – | 13291 |
|
|
2024
Q4 | $172K | Buy |
+10,900
| New | +$164K | ﹤0.01% | 10891 |
|
|
2022
Q3 | – | Sell |
-20,000
| Closed | -$222K | – | 13960 |
|
|
2022
Q2 | $222K | Sell |
20,000
-3,000
| -13% | -$32.6K | ﹤0.01% | 10375 |
|
|
2022
Q1 | $256K | Buy |
+23,000
| New | +$261K | ﹤0.01% | 10661 |
|
|
2021
Q4 | – | Sell |
-111,500
| Closed | -$1.45M | – | 13765 |
|
|
2021
Q3 | $1.45M | Buy |
111,500
+58,000
| +108% | +$773K | ﹤0.01% | 6568 |
|
|
2021
Q2 | $787K | Buy |
53,500
+31,500
| +143% | +$441K | ﹤0.01% | 8421 |
|
|
2021
Q1 | $270K | Sell |
22,000
-39,500
| -64% | -$507K | ﹤0.01% | 10822 |
|
|
2020
Q4 | $877K | Buy |
61,500
+8,000
| +15% | +$108K | ﹤0.01% | 7025 |
|
|
2020
Q3 | $744K | Sell |
53,500
-18,500
| -26% | -$220K | ﹤0.01% | 6830 |
|
|
2020
Q2 | $763K | Buy |
72,000
+27,500
| +62% | +$280K | ﹤0.01% | 6488 |
|
|
2020
Q1 | $359K | Buy |
44,500
+5,000
| +13% | +$41.7K | ﹤0.01% | 7634 |
|
|
2019
Q4 | $321K | Buy |
+39,500
| New | +$312K | ﹤0.01% | 7889 |
|
|
2019
Q3 | – | Sell |
-29,500
| Closed | -$221K | – | 10709 |
|
|
2019
Q2 | $221K | Buy |
+29,500
| New | +$232K | ﹤0.01% | 8934 |
|
|
2018
Q4 | – | Sell |
-37,000
| Closed | -$256K | – | 9794 |
|
|
2018
Q3 | $256K | Buy |
+37,000
| New | +$247K | ﹤0.01% | 7781 |
|
|
2018
Q2 | – | Sell |
-32,000
| Closed | -$209K | – | 10255 |
|
|
2018
Q1 | $209K | Sell |
32,000
-2,500
| -7% | -$17.5K | ﹤0.01% | 8256 |
|
|
2017
Q4 | $259K | Sell |
34,500
-494,500
| -93% | -$3.56M | ﹤0.01% | 7828 |
|
|
2017
Q3 | $3.77M | Buy |
529,000
+495,500
| +1,479% | +$3.56M | ﹤0.01% | 2891 |
|
|
2017
Q2 | $282K | Buy |
33,500
+2,500
| +8% | +$20.3K | ﹤0.01% | 7695 |
|
|
2017
Q1 | $249K | Buy |
+31,000
| New | +$268K | ﹤0.01% | 7677 |
|
|
2016
Q4 | – | Sell |
-22,000
| Closed | -$204K | – | 10048 |
|
|
2016
Q3 | $204K | Buy |
+22,000
| New | +$210K | ﹤0.01% | 7556 |
|
|
2016
Q1 | – | Sell |
-78,000
| Closed | -$722K | – | 9540 |
|
|
2015
Q4 | $722K | Buy |
78,000
+55,500
| +247% | +$608K | ﹤0.01% | 6074 |
|
|
2015
Q3 | $288K | Buy |
+22,500
| New | +$279K | ﹤0.01% | 8104 |
|
|
2014
Q3 | – | Sell |
-27,500
| Closed | -$237K | – | 9849 |
|
|
2014
Q2 | $237K | Sell |
27,500
-26,000
| -49% | -$219K | ﹤0.01% | 8782 |
|
|
2014
Q1 | $470K | Buy |
53,500
+15,000
| +39% | +$130K | ﹤0.01% | 6828 |
|
|
2013
Q4 | $316K | Buy |
+38,500
| New | +$305K | ﹤0.01% | 7501 |
|
Other funds holding RDY
AIM
Jeff Yass's RDY Position: Q2 2026 in Review
Jeff Yass sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 42,300 shares — an estimated $571K sold.
Jeff Yass first reported a position in RDY in Q2 2013 and held it in 20 quarters. The position peaked at $2.79M in Q4 2015. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Jeff Yass reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 42,300 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $571K.
- Jeff Yass first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 20 quarters.
- Jeff Yass's Dr. Reddy's Laboratories position peaked at $2.79M in Q4 2015.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.